A
Alta Pharmaceutical Research Center | Dunwoody, GA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ARO-APOC3
Obicetrapib
Bococizumab
TI-162
TI-166
Insulin aspart
Anakinra
Apixaban
TI-161
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 11 total trials
This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo
This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with underlying heterozygous familial hypercholester...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Dyslipidemias
Drug: Placebo
Drug: Obicetrapib
This is an open-label extension of the parent studies AROAPOC3-2001 and AROAPOC3-2002. Adult participants with dyslipidemia who completed the blinded...
Active, not recruiting
Dyslipidemias
Drug: ARO-APOC3
Trial sponsors
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems